Polypharmacology of Anti-Cancer Antibodies


Both biological and pathological networks acquire robustness due to their modular structures. Hence, effective pharmacological interception of oncogenic networks requires polypharmacology, namely the use of pharmaceutical... [ view full abstract ]


  1. Yosef Yarden (Weizmann Institute of Science)

Topic Areas

Drug target discovery and integration with individualized therapy, integration of diagnosi , Personalized therapies (cancer, immunology, infectious diseases, clinical case studies, et


PL1a » Plenary Speeches (09:05 - Monday, 25th June, Amphitheater)

Presentation Files

The presenter has not uploaded any presentation files.